Emma Di Carlo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Emma Di Carlo

Showing results (41-50 of 94) with videos related to

Pageof 10

Sort By:

Oncotarget|April 1, 2014

The antitumor potential of Interleukin-27 in prostate cancerEmma Di Carlo, Carlo Sorrentino, Alessia Zorzoli, et al.

Blood|July 31, 2010

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cellsClaudia Cocco, Sara Canale, Chiara Frasson, et al.

Cytokine|March 31, 2004

Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitisTonino Alonzi, Ian P Newton, Paul J Bryce, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007

Endogenous IL-12 triggers an antiangiogenic program in melanoma cellsIrma Airoldi, Emma Di Carlo, Claudia Cocco, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004

IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic miceEmma Di Carlo, Alberto Comes, Anna Maria Orengo, et al.

Immunology Letters|August 14, 2010

Direct inhibition of human acute myeloid leukemia cell growth by IL-12Elisa Ferretti, Emma Di Carlo, Claudia Cocco, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024

Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editingCristiano Fieni, Stefania Livia Ciummo, Carlo Sorrentino, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026

Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustionSimona Marchetti, Carlo Sorrentino, Cristiano Fieni, et al.

Oncotarget|February 18, 2015

SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expressionSilvia Esposito, Marco V Russo, Irma Airoldi, et al.

Clinical and Translational Medicine|February 26, 2021

Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signalingCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Pageof 10

Search research articles

Showing results (41-50 of 94) with videos related to

Sort By:

Pageof 10

Oncotarget|April 1, 2014

The antitumor potential of Interleukin-27 in prostate cancerEmma Di Carlo, Carlo Sorrentino, Alessia Zorzoli, et al.

Blood|July 31, 2010

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cellsClaudia Cocco, Sara Canale, Chiara Frasson, et al.

Cytokine|March 31, 2004

Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitisTonino Alonzi, Ian P Newton, Paul J Bryce, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007

Endogenous IL-12 triggers an antiangiogenic program in melanoma cellsIrma Airoldi, Emma Di Carlo, Claudia Cocco, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004

IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic miceEmma Di Carlo, Alberto Comes, Anna Maria Orengo, et al.

Immunology Letters|August 14, 2010

Direct inhibition of human acute myeloid leukemia cell growth by IL-12Elisa Ferretti, Emma Di Carlo, Claudia Cocco, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024

Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editingCristiano Fieni, Stefania Livia Ciummo, Carlo Sorrentino, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026

Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustionSimona Marchetti, Carlo Sorrentino, Cristiano Fieni, et al.

Oncotarget|February 18, 2015

SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expressionSilvia Esposito, Marco V Russo, Irma Airoldi, et al.

Clinical and Translational Medicine|February 26, 2021

Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signalingCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Pageof 10